Nozin in the News


American Journal of Infection Control HomeBaylor SSI Study In Press at AJIC


Now available at the AJIC website is an In- Press article, "Perioperative participation of orthopedic patients and surgical staff in a nasal decolonization intervention to reduce Staphylococcus spp surgical site infections". Quoting from this Baylor study, which utilized a Nozin® protocol: “After implementation of an alcohol-based antiseptic nasal decolonization program in patients and members of our hospital spine surgery group, Staphylococcus spp SSIs were significantly reduced from baseline over the subsequent 15-month period.” An earlier phase of this Baylor study was well received as a poster at IDSA ID Week 2016. The new In-Press article will also be published in an upcoming AJIC issue.


ict-logoNew article by Sue Barnes, RN, CIC, the former national program leader for infection prevention at Kaiser Permanente. In the article "Nasal Decolonization and HAI Prevention: Application and Evidence", the author presents a very interesting review and comparison of nasal decolonization products, including Nozin. This article is on page 22 in the December 2016 issue of Infection Control Today.

Link to article: Click Here


healthcare-logoHealthcare Purchasing News November 2016 issue contains the article entitled "Strength in Numbers". In this article the author, Valerie Dimond, makes a case for stronger cooperation in achieving goals of Antimicrobial Stewardship Programs (ASPs). John Willimann, President of Global Life Technologies, Corp., is quoted: "Balancing the risk associated with prophylactic antimicrobial use against the outcome benefit (fewer HAIs) is one of the biggest challenges facing healthcare providers today. Fortunately, non-antibiotic, antiseptic solutions designed for infection control to reduce bacterial burden have emerged as a standard of care. In lieu of mupirocin antibiotic, Nozin nasal antiseptics are being used for patients perioperatively, not just in pre-op, as well as for ICU and other high risk patients who are susceptible to pathogens.”

Link to article: Click Here


ids-logoOctober 2016. At the IDSA annual meetingID Week 2016, Baylor Orthopedic and Spine Hospital at Arlington presented results of a study entitled: Pre- and Post-Operative Participation of Orthopedic Patients and Surgical Staff in a Novel Intervention to Reduce Staphylococcus aureus Infection. This is the IDWeek link to the abstract on the Baylor study on the perioperative use of Nozin® Nasal Sanitizer® by surgical patients and surgical staff.  For this 9 month Baylor study: “The inclusion of alcohol-based nasal antiseptic use by both surgical patients and staff in IC protocols during the peri-operative period resulted in a marked decrease in SSIR.” The antiseptic utilized was Nozin® Nasal Sanitizer®. The study summary stated: “The addition of nasal antiseptic to our standard procedures for reducing skin carriage resulted in a marked and significant decrease in S. aureus SSIs.”


apic-logoAt the APIC 2016 conference, Nina Deatherage, BSN, RN, PHN, CIC, and Infection Control Lead at Marshall Medical Center presented results of eliminating MRSA contact precautions at Marshall. This poster abstract concluded: “Elimination of CP in MRSA non-infected patients while maintaining low infection rates and improving staff and patient satisfaction was achieved with IC protocols utilizing nasal and skin decolonization. A significant reduction in CP-related PPE costs also resulted.”5 Nozin® Nasal Sanitizer® antiseptic was used to achieve nasal decolonization. More information at AJIC site.


 March 2015. Reuters is among a number of news outlets that have run the press article: “Nozin Nasal Drug Reduces Risk and Cost Associated with MRSA at Marshall Medical Center”. Here is a link to the BusinessWire coverage. In the article, Brian Kendler, RN, Infection Preventionist on the Marshall infection control team notes, “Our patients seem to really like the Nozin product as evidenced by both use compliance and the increased satisfaction verbalized since implementation. It’s been a true win-win.”


 October 2014. MarketWatch  has published the press article: “Nozin Antiseptic Drug Effective in Treating Staph aureus Nasal Carriage”. Here is a link to the MarketWatch website coverage. The article includes a quote from Dr. Shaun Nguyen,  the principal investigator for the research, “We were open-minded and wanted to come up with a hypothesis to determine whether or not an economical intervention could reduce staph carriage…it worked." “This is a low-cost intervention that potentially can impact patients’ health in a significant way,” says Dr. Nguyen.


 October 2014. Federal Practitioner, a peer-reviewed journal for health professionals of the VA, DoD and PHS  has published the article: “A Nonantibiotic Way to Reduce S Aureus Carriage” for their Drug Monitor column. Here is a link to Federal Practitioner website for the article which reviews the clinical study conducted at MUSC demonstrating nasal carriage reduction of S. aureus and total bacteria without antibiotics.


American Journal of Infection Control Home June 2014. The American Journal of Infection Control (AJIC) has in press the article: “Reduction of nasal Staphylococcus aureus carriage in health care professionals by treatment with a nonantibiotic, alcohol-based nasal antiseptic”. Here is a link to AJIC website for the article on the clinical study which showed that Nozin® Nasal Sanitizer® antiseptic was effective in reducing Staph aureus and total bacterial carriage.

Update. August 2014.  The major article on the peer reviewed study utilizing Nozin Nasal Sanitizer® is now published  in current August issue of the American Journal Of Infection Control. The study found that Nozin Nasal Sanitizer was " effective in reducing S aureus and total bacterial carriage, suggesting the usefulness of this approach as a safe, effective, and convenient alternative to antibiotic treatment." Further insight on this study can be reviewed at nozinpro.com.


 May 2014. Reuters, Miami Herald, Yahoo carry the article: “Nozin Nasal Sanitizer® Hygiene Breakthrough Part of Riviera’s State of the Art Healthcare”

Here's a link the article on how Riviera Health Resort, a leading post acute care facility in Coral Gables, Florida, adopted the Nozin® Nasal Sanitizer® program.


eHealth Radio April 2012. Listen to interview. John Willimann, the President and Chief Science Officer of Nozin joins the show. Listen as host Eric Michaels & guest John Willimann discuss Nozin® Nasal Sanitizer® and Allergy Master®.


The Wall Street Journal

Wall Street Journal December 2011. Read WSJ article. Nozin® Nasal Sanitizer® was one of the products featured in the Wall Street Journal article. "Ritu Goel, a Pawtucket, R.I. ear, nose and throat specialist ... says she uses Nozin when traveling and when seeing... patients. She recommends it to patients who regularly get winter sinus infections. The alcohol prevents germs from 'festering in the nose,' she says." "It's like a hand sanitizer for your nose." says Nozin president John Willimann.


ABC 7 News

KABC TV Los Angeles February 2011. KABC TV News Clip on Nozin. " Dr. Lorraine Smith, an ear, nose and throat specialist at Osborne Head and Neck Institute in Los Angeles, believes the nose is where germ battles are won and lost. Dr. Smith came across Nozin at a medical trade show more than a year ago, and she's been recommending it ever since. "It's an over-the-counter nose antiseptic." Dr. Smith says to think of it as "hand sanitizer for the your sniffer."


The New York Times

New York Times December 2009. "Novel Anti-Germ Devices for Travelers"Quote: "Almost 90 percent of United States travelers say they are worried about germs while traveling...And 55 percent said they would request a new seat if their seatmate looked sick. While that’s not always possible given how tightly airlines are packing planes these days...for those who feel they need more protection, companies are offering new products [e.g. Nozin Nasal Sanitizer] for germ-a-phobes on the go."


Parents Magazine

Parents Magazine January 2009. "Smart Product Pick: Nozin Nasal Sanitizer " Quote: "Swab...your child's nostrils before he heads to school; studies show it will help reduce the risk of ... germs."


Positive Thinking Magazine

Positive Thinking Magazine May/June 2008. "Trip Picks: With [Nozin Nasal Sanitizer], you're good to go."


Where Magazine NY

WHERE Magazine New York May/June 2008. Quote: "Crowded airplane cabins are breeding grounds for germs. Those seeking a barrier against harmful bacteria might want to consider Nozin Nasal Sanitizer."


Executive Travel

Executive Travel Magazine May 2008. Cover: "Insider Tips for Business Travel" Quote: "You wouldn’t think of getting onboard without a tube of hand sanitizer. Take it to the next level... and duck into the lav to swab your nostrils with Nozin."


Oracle ProfitOracle's Profit Magazine February 2008. Quote: "Use Nozin in combination with other good hygiene habits to keep yourself in fighting shape. Your boss will appreciate it, too."


NickNickelodeon's Parentsconnect.com. January 16, 2008. Daily Good. Quote:"We recommend Nozin. We like to think of (Nozin) as a slightly saner option to building your kid a germ-free bubble suit...We have a winner."


The Today ShowThe Today Show November 29, 2007. NBC Today Show is the highest-rated national morning TV show. Segment: “What to try while you fly.”


MSNBCMSNBC.com (visits monthly: 1,000,000) Nov 28, 2007. Quote: “With plenty of time ahead of you from takeoff to touchdown, the plane can be the perfect place for some pampering. Start by blocking germs with Nozin's nifty little swabs .”


New York MagazineNew York Magazine (circulation est: 450,000) November 25, 2007. "Stay Healthy" Quote: “A little gross, but effective.”

Links for Health Professionals.


Feel free to contact us with any questions or comments you may have.


Private, secure, spam-free.



Health Professionals:
Request Nozin® samples for your facility.
© 2004-2017 Global Life Technologies Corp. All rights reserved. Nozin® Nasal Sanitizer® antiseptic is an OTC topical antiseptic drug and no claim is made that it has an effect on any specific disease.

Complete the fields below to get
the latest news, health tips and special offers.





Private, secure, spam-free.